Royalty Pharma plc (RPD)
Munich
Real-time Data
06:00 AM
Day's Range
52.1952 wk Range
30.16Overview - RPD - Royalty Pharma plc
Key Statistics
Valuation
Enterprise Value
26.39B
P/E (Trailing)
‪32.82‬
PEG Ratio
‪-0.46‬
Price / Sales (TTM)
‪11.89‬
Price / Book
‪3.97‬
EV / EBITDA
‪19.78‬
Profitability
Profit Margin
‪32.01%‬
Operating Margin
‪19.74%‬
Return on Assets
‪5.08%‬
Return on Equity
‪13.96%‬
Ownership
Shares Outstanding
875.98M
Float
415.52M
Held by Insiders
‪6.48%‬
Held by Institutions
‪87.30%‬
Price stats
Beta
‪0.42‬
50-Day Avg
‪49.93‬
200-Day Avg
‪41.49‬
Dividends
Payout Ratio
‪48.92%‬
Frequency
Quarterly
Shariah Compliance
Report Date: Feb 16, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - RPD - Royalty Pharma plc
Peers - RPD - Royalty Pharma plc
Peer Comparison
Compared with companies in Biotechnology listed on Munich.
- RPDMunichRoyalty Pharma plc29.48BMarket Cap+39.90%52-week change31.69P/E (Trailing)‪32.01%‬Profit Margin
- 1AEAMunichargenx SE American Depositary Receipt53.48BMarket Cap+35.80%52-week change37.40P/E (Trailing)‪32.26%‬Profit Margin
- 0QFMunichModerna, Inc.47.90BMarket Cap+81.73%52-week change25.19P/E (Trailing)‪-141.42%‬Profit Margin
- 5VAMunichVaxcyte, Inc.7.96BMarket Cap+50.65%52-week change-9.50P/E (Trailing)‪0.00%‬Profit Margin
- 1HMMunichAdaptive Biotechnologies Corporation3.49BMarket Cap+50.16%52-week change-56.23P/E (Trailing)‪-20.72%‬Profit Margin
- 4DNMunichDenali Therapeutics Inc.3.42BMarket Cap+38.19%52-week change-7.22P/E (Trailing)‪0.00%‬Profit Margin
- 30JMunichIdeaya Biosciences Inc.2.55BMarket Cap+31.06%52-week change-21.08P/E (Trailing)‪-62.17%‬Profit Margin
Profile Summary - RPD - Royalty Pharma plc
About
Royalty Pharma plc is the world's largest buyer of biopharmaceutical royalties and a leading funder of innovation in the life sciences sector. The company acquires royalties entitling it to payments based on net sales of approved therapies and development-stage product candidates, partnering with innovators from…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
